A peptide blend is a single vial containing two or more distinct peptides combined by the manufacturer at a fixed ratio, rather than a single-compound peptide sold on its own. Blends exist because certain peptides are commonly researched together for overlapping or complementary mechanisms, such as CJC-1295 and Ipamorelin, so combining them into one vial saves the researcher from reconstituting and drawing two separate vials for every dose. The tradeoff is that a blend locks in a fixed dose ratio between its components, which changes how dosing math has to be approached compared to a single-peptide vial.
How blend dosing differs from single-peptide dosing
With a single peptide, calculating a dose is a matter of knowing the vial's total peptide mass, how much bacteriostatic water was used during reconstitution, and the resulting concentration in mg/mL. A blend adds a second variable: the vial's total mass is split between two or more peptides at a stated ratio (for example, a "5mg/5mg" CJC-1295/Ipamorelin blend contains 5mg of each, not 5mg total), so pulling a dose on a U-100 insulin syringe delivers both components simultaneously in that fixed proportion. Getting this wrong, by treating the label's total mass as if it were a single-compound concentration, is the most common dosing error with blends, since it silently doubles or otherwise skews the calculated dose per component. Because the ratio can't be adjusted after the vial is mixed, anyone who wants an independent ratio between two peptides needs to buy and reconstitute them separately rather than as a blend. For the actual math, the blend calculator is built specifically to handle multi-component vials and convert a stated ratio into a per-component dose and syringe volume.
Blend vs. stack
"Blend" and "stack" are often used interchangeably in casual discussion, but they describe different things. A blend is a single vial, pre-combined by the manufacturer at a fixed ratio the researcher can't alter. A stack is a broader term for any combination of peptides used together in a protocol, whether they come from one blended vial or from several separate vials dosed independently, each with its own reconstitution and its own adjustable dose. A stack built from separate vials gives independent control over each compound's dose and timing; a blend trades that flexibility for convenience and, often, a lower per-vial cost than buying the same peptides separately.
Reading a blend's label carefully matters more than it does for a single peptide, since the stated total mass, the ratio between components, and the peptide concentration after reconstitution all have to be tracked together rather than as one number. A certificate of analysis from the supplier is also worth checking specifically for blends, since HPLC-MS testing needs to confirm the presence and ratio of each individual component, not just the total peptide content, which is a more complex verification than testing a single compound.
Storage and stability also carry more variables in a blend than in a single-peptide vial. Two peptides combined at synthesis don't necessarily share the same stability profile, decay rate, or sensitivity to temperature and light once reconstituted, so a blend's storage guidance is set to protect its least stable component, even if the other component alone could tolerate looser handling. This is one more reason blends are treated as a distinct product category rather than simply a shortcut for combining peptides a researcher would otherwise reconstitute separately: the fixed ratio, the combined label math, and the shared storage profile all have to be accounted for together once the components are mixed into one vial.